Prevalence of factor V (Q506) and prothrombin 20210 a mutations in an apparently healthy Icelandic population and patients suffering from venous thrombosis
Olafsson, I.; Hjaltadóttir, S.; Onundarson, P.T.; Pórarinsdóttir, R.; Haraldsdóttir, V.
Thrombosis and Haemostasis 79(3): 685-686
1998
ISSN/ISBN: 0340-6245 PMID: 9531063 Document Number: 484846
Document emailed within 1 workday
Related Documents
Mandavilli, B.; Shoup, R.M.; DiGiuseppe, J.A.; Rezuke, W.N.; Tsongalis, G.J. 2000: Concurrent factor V Leiden and prothrombin G20210A gene mutations in a patient with a history of recurrent thrombosis Connecticut Medicine 64(5): 259-261Zabalegui, N.; Montes, R.; Orbe, J.; Ayape, M.L.; Medarde, A.; Páramo, J.A.; Rocha, E. 1998: Prevalence of FVR506Q and prothrombin 20210A mutations in the Navarrese population Thrombosis and Haemostasis 80(3): 522-523
Reuner, K.H.; Ruf, A.; Grau, A.; Rickmann, H.; Stolz, E.; Jüttler, E.; Druschky, K.F.; Patscheke, H. 1998: Prothrombin gene G20210-->A transition is a risk factor for cerebral venous thrombosis Stroke 29(9): 1765-1769
Ara, R.; Afzal, H.; Qureshi, M.A.; Chaudhry, N.A. 1980: Prevalence of Widal antibodies in apparently healthy human population Jpma. Journal of the Pakistan Medical Association 30(12): 269-271
Souto, J.C.; Coll, I.; Llobet, D.; del Río, E.; Oliver, A.; Mateo, J.; Borrell, M.; Fontcuberta, J. 1998: The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population Thrombosis and Haemostasis 80(3): 366-369
Romero García, F.; Moller, M.; García Loera, M.; Hurtado Mendialdúa, F.; Sotomayor Martín del Campo, J.M.; Flores, S.; González, R.M. 1980: Prevalence of anemia and deficiencies for iron, folic acid and B12 vitamin in an apparently healthy population from 0 to 15 years of age and poor socio-economic level Sangre 25(5): 549-558
Halbmayer, W.M.; Mannhalter, C.; Feichtinger, C.; Rubi, K.; Fischer, M. 1992: The prevalence of factor XIi deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism Thrombosis and Haemostasis 68(3): 285-290
Tsiguleva, O.A. 1988: Study of the Willebrand factor in patients with venous thrombosis Laboratornoe Delo 2: 7-9
Zuazu-Jausoro, I.; Sanchez, I.; Fernandez, M.C.; Corral, J.; Gonzalez-Conejero, R.; Vicente, V. 1998: Portal and mesenteric venous thrombosis in a patient heterozygous for the 20210 a allele of the prothrombin gene Haematologica 83(12): 1129-1130
Lopaciuk, S.; Bykowska, K.; Kopeć, M. 1996: Prevalence of heparin cofactor Ii deficiency in patients with a history of venous thrombosis Polish Journal of Pharmacology 48(1): 109-111
Akhavan, S.; Lavoretano, S.; Chantarangkul, V.; Mannucci, P.M. 2002: Plasma prothrombin levels are not associated with mutations in the promoter region of the prothrombin gene Thrombosis and Haemostasis 88(5): 877-878
Koopman, K.; Uyttenboogaart, M.; Vroomen, P.C.A.J.; van der Meer, J.; De Keyser, J.; Luijckx, G-Jan. 2009: Risk factors for cerebral venous thrombosis and deep venous thrombosis in patients aged between 15 and 50 years Thrombosis and haemostasis 102(4): 620-622
Kim, S.W.; Charallel, J.T.; Park, K.W.; Bauerle, L.C.; Shang, C.C.; Gordon, S.K.; Bauman, W.A. 1994: Prevalence of deep venous thrombosis in patients with chronic spinal cord injury Archives of Physical Medicine and Rehabilitation 75(9): 965-968
González Ordóñez, A.J.; Medina Rodriguez, J.M.; Fernández Alvarez, C.R.; Macias Robles, M.D.; Coto García, E. 1998: A patient homozygous for mutation 20210A in the prothrombin gene with venous thrombosis and transient ischemic attacks of thrombotic origin Haematologica 83(11): 1050-1051
Velásquez-Jones, L.; Mougrabi-Mizrahi, M.; Gordillo-Paniagua, G.; Heredia-Duarte, A. 1977: Occurence of renal diseases and arterial hypertension in an apparently healthy university population Gaceta Medica de Mexico 113(11): 543-547
Margaglione, M.; Cappucci, G.; Colaizzo, D.; Pirro, L.; Vecchione, G.; Grandone, E.; Di Minno, G. 1998: Fibrinogen plasma levels in an apparently healthy general population--relation to environmental and genetic determinants Thrombosis and Haemostasis 80(5): 805-810
Mamo, Y.; Belachew, T.; Abebe, W.; Gebre-Selassie, S.; Jira, C. 2007: Pattern of widal agglutination reaction in apparently healthy population of Jimma town, southwest Ethiopia Ethiopian Medical Journal 45(1): 69-77
Streckfus, C.F.; Strahl, R.C.; Welsh, S. 1990: Anti-hypertension medications: an epidemiological factor in the prevalence of root decay among geriatric patients suffering from hypertension Clinical Preventive Dentistry 12(3): 26-29
Martinelli, I.; Landi, G.; Merati, G.; Cella, R.; Tosetto, A.; Mannucci, P.M. 1996: Factor V gene mutation is a risk factor for cerebral venous thrombosis Thrombosis and Haemostasis 75(3): 393-394
Dahlbäck, B. 1997: Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis Thrombosis and Haemostasis 78(1): 483-488